drugset
drugset / Trial / NCT03194009

PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment

NCT03194009 ↗

Unknown 3060 enrolled National Institute of Public Health, Mexico Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · collabMinistry of Health, Mexico City · collabUniversity of California, San Francisco · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The PRuDENTE study proposes to assess if metformin therapy a viable, efficient and cost-effective intervention to decrease the incidence of type 2 diabetes (DMT2) in adult subjects with obesity and pre-diabetes in Mexico City. Half of the individuals recruited will receive as intervention, metformin and lifestyle modification therapy and the other half will receive only lifestyle modification therapy.

Timeline

Start
2017-08-10
Primary completion
2020-12-31
Completion
2022-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 850 mg —

Indications

prediabetes syndrome type 2 diabetes mellitus